0001596771-17-000020.txt : 20170314 0001596771-17-000020.hdr.sgml : 20170314 20170314173307 ACCESSION NUMBER: 0001596771-17-000020 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20170310 FILED AS OF DATE: 20170314 DATE AS OF CHANGE: 20170314 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Gemphire Therapeutics Inc. CENTRAL INDEX KEY: 0001638287 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 472389984 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 17199 N. LAUREL PARK DRIVE STREET 2: SUITE 401 CITY: LIVONIA STATE: MI ZIP: 48152 BUSINESS PHONE: 248-980-6538 MAIL ADDRESS: STREET 1: 17199 N. LAUREL PARK DRIVE STREET 2: SUITE 401 CITY: LIVONIA STATE: MI ZIP: 48152 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Gullans Steven R. Ph.D. CENTRAL INDEX KEY: 0001571997 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37809 FILM NUMBER: 17689093 MAIL ADDRESS: STREET 1: C/O EXCEL VENTURE MANAGEMENT, LLC STREET 2: 800 BOYLSTON ST., STE 2825 CITY: BOSTON STATE: MA ZIP: 02199 4 1 primary_doc.xml PRIMARY DOCUMENT X0306 4 2017-03-10 0 0001638287 Gemphire Therapeutics Inc. GEMP 0001571997 Gullans Steven R. Ph.D. 17199 N. LAUREL PARK DRIVE SUITE 401 LIVONIA MI 48152 1 0 0 0 Common Stock 2017-03-10 4 P 0 52798 9.47 A 858823 I Held by Excel Venture Fund II, L.P. Warrant to Purchase Common Stock 10.4 2017-03-10 4 P 0 39599 9.47 A 2017-03-10 2022-03-15 Common Stock 39599 39599 I Held by Excel Venture Fund II, L.P. The shares of common stock and warrants were purchased as part of a private placement pursuant to a Securities Purchase Agreement whereby the Issuer sold units consisting of one share of the Issuer's common stock and a warrant to purchase 0.75 shares of the Issuer's common stock at a per unit price of $9.47. The private placement is expected to close on March 15, 2017. The reporting person, as the Manager of Excel Venture Fund II, L.P., beneficially owns the reported securities indirectly, but disclaims beneficial ownership of the securities except to the extent of his pecuniary interest therein. Stephanie Swan, by Power of Attorney 2017-03-14